Predicting whether or not cancer patients will develop another primary tumor or experience a relapse is a tricky business. University of Texas MD Anderson Cancer Center's Xifeng Wu and her colleagues have found 18 SNPs in microRNA biogenesis genes and miRNA binding sites that are associated with an increased risk of head and neck cancer patients developing a second primary tumor, or relapsing.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.